Potential role of IgM-enriched immunoglobulin as adjuvant treatment for invasive meningococcal disease

Intensive Care Med. 2018 Feb;44(2):261-262. doi: 10.1007/s00134-017-4957-z. Epub 2017 Nov 9.

GISA/SIMIT Meningitis Study Group:
Ferdinando Cellai, Jessica Mencarini, Rosario Spina, Michele Trezzi, Spartaco Sani, Paolo Roncucci, Carolina Rescigno, Pasquale Pagliano, Vittorio Attanasio, Raffaele Di Sarno, Alessandro Viola, Cristiano Minucci, Italo Calamai, Simona Fortunato, Enrico Tagliaferri, Carlo Pallotto

¹ First Division of Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera dei Colli, Naples, Italy.
² Intensive Care Unit, Cotugno Hospital, Azienda Ospedaliera dei Colli, Naples, Italy.
³ Infectious Diseases Clinic, Nuovo Santa Chiara University Hospital, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
⁴ Emergency Medicine Unit, Nuovo Santa Chiara University Hospital, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
⁵ Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
⁶ Pharmaceutical Department, Azienda Ospedaliera Universitaria Pisana, Santa Chiara, Pisa, Italy.
⁷ Infectious Diseases Unit, S. Maria Annunziata Hospital, Central Tuscany Health Authority, Florence, Italy.
⁸ Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
⁹ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
¹⁰ Infectious Diseases Clinic, Nuovo Santa Chiara University Hospital, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy. menichettifrancesco@gmail.com.

No abstract available

Publication types